EEE

ELICERA THERAPEUTICS AB

No trades
See on Supercharts

ELIC fundamentals

An in-depth look to ELICERA THERAPEUTICS AB operating, investing, and financing activities

ELIC free cash flow for Q2 24 is -7.73 M SEK. For 2023, ELIC free cash flow was -14.92 M SEK and operating cash flow was -14.92 M SEK.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: SEK
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth